R1	Has_negation Arg1:T4 Arg2:T3	
R2	AND Arg1:T2 Arg2:T4	
*	OR T5 T6
R3	Has_multiplier Arg1:T7 Arg2:T8	
*	OR T11 T10
R4	Has_qualifier Arg1:T9 Arg2:T11	
*	OR T13 T15 T16 T17 T14
R5	Has_qualifier Arg1:T13 Arg2:T19	
R6	Has_negation Arg1:T13 Arg2:T18	
R7	Has_temporal Arg1:T22 Arg2:T21	
R8	Has_qualifier Arg1:T13 Arg2:T22	
R9	Has_qualifier Arg1:T23 Arg2:T24	
R10	AND Arg1:T23 Arg2:T25	
R11	AND Arg1:T29 Arg2:T27	
R12	Has_value Arg1:T29 Arg2:T28	
*	OR T30 T31
R13	AND Arg1:T32 Arg2:T30	
R14	AND Arg1:T34 Arg2:T35	
R15	Has_temporal Arg1:T38 Arg2:T39	
R16	Has_temporal Arg1:T32 Arg2:T40	
R17	Has_qualifier Arg1:T42 Arg2:T41	
R18	Has_temporal Arg1:T42 Arg2:T26	
R19	Has_qualifier Arg1:T42 Arg2:T43	
R20	multi Arg1:T44 Arg2:T45	
R21	Has_qualifier Arg1:T42 Arg2:T44	
*	OR T35 T36
T1	Person 0 5	Women
T2	Condition 9 32	child-bearing potential
T3	Negation 38 44	do not
T4	Procedure 54 76	adequate contraception
T5	Condition 79 87	Pregnant
T6	Condition 91 100	lactating
T7	Drug 126 154	primary chemotherapy regimen
T8	Multiplier 112 125	more than one
T9	Condition 181 193	malignancies
T10	Qualifier 172 180	previous
T11	Qualifier 157 168	Concomitant
T13	Condition 235 245;263 274	basal cell skin cancer
T14	Condition 249 274	squamous cell skin cancer
T15	Condition 276 299	in situ cervical cancer
T16	Condition 301 321	incidental carcinoid
T17	Condition 326 338	other cancer
T18	Negation 199 215	the exception of
T19	Qualifier 216 234	adequately treated
T21	Temporal 384 395	for 5 years
T22	Qualifier 362 383	has been disease free
T23	Condition 418 427	infection
T24	Qualifier 398 417	Active uncontrolled
T25	Drug 438 449	antibiotics
T27	Procedure 575 584	radiation
T28	Value 588 601	more than 10%
T29	Qualifier 605 609	bone
T30	Drug 633 642	topotecan
T31	Drug 646 657	gemcitabine
T32	Observation 618 627	treatment
T34	Condition 660 676	Hypersensitivity
T35	Drug 680 692	camptothecin
T36	Drug 696 716	nucleoside analogues
T38	Drug 729 750	investigational agent
T39	Temporal 751 765	within 30 days
T40	Temporal 612 617	Prior
T26	Temporal 452 462	Concurrent
T41	Qualifier 463 469	severe
T42	Condition 470 486	medical problems
T43	Qualifier 527 563	limit full compliance with the study
T44	Qualifier 487 514	unrelated to the malignancy
T45	Condition 504 514	malignancy
